Glecaprevir and pibrentasvir and Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
Determining the interaction of Glecaprevir and pibrentasvir and Kisqali Femara Co-Pack 600 mg-2.5 mg Dose and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: glecaprevir / pibrentasvir
Brand name: Mavyret
Synonyms: Glecaprevir and Pibrentasvir
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Glecaprevir and pibrentasvir-Kitabis Pak
- Glecaprevir and pibrentasvir-Kitabis Pak inhalation
- Glecaprevir and pibrentasvir-Klofensaid II
- Glecaprevir and pibrentasvir-Klonopin
- Glecaprevir and pibrentasvir-Klonopin Wafer
- Glecaprevir and pibrentasvir-Klonopin Wafers
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Gleevec
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Glenmax PEB DM
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Glenmax PEB DM FORTE
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Gleolan
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Gleostine
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Gliadel